OmpA-like protein Loa22 from Leptospira interrogans serovar Lai is cytotoxic to cultured rat renal cells and promotes inflammatory responses

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 1, 2010, Pages 70-79

  Zhang, Ying ^a   Bao, Lang ^a   Zhu, Hailong ^a   Huang, Bi ^a   Zhang, Huidong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cytotoxicity; Leptospirosis; Loa22; Renal proximal tubule cells; Toll like receptor 2; Tubulointerstitial nephritis

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; OMPA OUTER MEMBRANE PROTEINS; OUTER MEMBRANE PROTEIN;

ANIMAL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECT; FLOW CYTOMETRY; GENETIC TRANSFECTION; KIDNEY PROXIMAL TUBULE; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MOLECULAR GENETICS; PATHOLOGY; RAT;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CCL2; FLOW CYTOMETRY; KIDNEY TUBULES, PROXIMAL; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MOLECULAR SEQUENCE DATA; RATS; TRANSFECTION;

ESCHERICHIA COLI; LEPTOSPIRA INTERROGANS; LEPTOSPIRA INTERROGANS SEROVAR LAI; RATTUS;

EID: 73549115095     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp109     Document Type: Article

References (43)

1. McBride AJ, Athanazio DA, Reis MG and Ko AI. Leptospirosis. Curr Opin Infect Dis 2005, 18: 376-386.
2. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA and Levett PN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003, 3: 757-771.
3. Levett PN. Leptospirosis. Clin Microbiol Rev 2001, 14: 296-326.
4. Farr RW. Leptospirosis. Clin Infect Dis 1995, 21: 1-6.
5. WHO. Leptospirosis worldwide, 1999. Wkly Epidemiol Rec 1999, 74: 237-242.
6. Sitprija V, Pipatanagul V, Mertowidjojo K, Boonpucknavig V and Boonpucknavig S. Pathogenesis of renal disease in leptospirosis: clinical and experimental studies. Kidney Int 1980, 17: 827-836.
7. Yang CW, Wu MS and Pan MJ. Leptospirosis renal disease. Nephrol Dial Transplant 2001, 16: 73-77.
8. Barbosa AS, Abreu PA, Neves FO, Atzingen MV, Watanabe MM, Vieira ML and Morais ZM, et al. A newly identified leptospiral adhesin mediates attachment to laminin. Infect Immun 2006, 74: 6356-6664.
9. Lee SH, Kim S, Park SC and Kim MJ. Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells. Infect Immun 2002, 70: 315-322.
10. Cullen PA, Haake DA and Adler B. Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev 2004, 28: 291-318.
11. Nascimento AL, Ko AI, Martins EA, Monteiro-Vitorello CB, Ho PL, Haake DA and Verjovski-Almeida S, et al. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol 2004, 186: 2164-2172.
12. Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H and Zhang YX, et al. Unique and physiological and pathogenic features of Leptospira interrogans revealed by whole genome sequencing. Nature 2003, 422: 888-893.
13. Fagan RP and Smith SG. The Hek outer membrane protein of Escherichia coli is an auto-aggregating adhesin and invasion. FEMS Microbiol Lett 2007, 269: 248-255.
14. Teng CH, Xie Y, Shin S, Di Cello F, Paul-Satyaseela M, Cai M and Kim KS. Effects of OmpA deletion on expression of type 1 fimbriae in Escherichia coli K1 strain RS218 and on the association of E. coli with human brain microvascular endothelial cells. Infect Immun 2006, 74: 5609-5616.
15. Wooster DG, Maruvada R, Blom AM and Prasadarao NV. Logarithmic phase Escherichia coli K1 efficiently avoids serum killingby promoting C4bp-mediated C3b andC4b degradation. Immunology 2006, 117: 482-493.
16. Torres AG, Li Y, Tutt CB, Xin L, Eaves-Pyles T and Soong L. Outer membrane proteinA of Escherichia coli O157:H7 stimulates dendritic cell activation. Infect Immun 2006, 74: 2676-2685.
17. Koizumi N and Watanabe H. Molecular cloning and characterization of a novel leptospiral lipoprotein with OmpA domain. FEMS Microbiol Lett 2003, 226: 215-219.
18. Picardeau M, Bulach DM, Bouchier C, Zuerner RL, Zidane N, Wilson PJ and Creno S, et al. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One 2008, 3: e1607.
19. Gamberini M, Gómez RM, Atzingen MV, Martins EA, Vasconcellos SA, Romero EC and Leite LC, et al. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol Lett 2005, 244: 305-313.
20. Yang HL, Zhu YZ, Qin JH, He P, Jiang XC, Zhao GP and Guo XK. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. BMC Genomics 2006, 7: 293.
21. Nally JE, Whitelegge JP, Bassilian S, Blanco DR and Lovett MA. Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect Immun 2007, 75: 766-773.
22. Kirschning CJ and Schumann RR. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol 2002, 270: 121-144.
23. Jeannin P, Magistrelli G, Goetsch L, Haeuw JF, Thieblemont N, Bonnefoy JY and Delneste Y. Outer membrane protein A(OmpA): a new pathogenassociated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine 2002, 20: A23-A27.
24. Morrison WI and Wright NG. Canine leptospirosis:An immunopathological study of interstitial nephritis due to Leptospira canicola. J Pathol 1976, 120: 83-89.
25. Athanazio DA, Silva EF, Santos CS, Rocha GM, Vannier-Santos MA, McBride AJ and Ko AI, et al. Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans. Acta Trop 2008, 105: 176-180.
26. Ristow P, Bourhy P, da Cruz McBride FW, Figueira CP, Huerre M, Ave P and Girons IS, et al. The OmpA-like protein Loa22 is essential for Leptospiral virulence. PLoS Pathog 2007, 3: e97.
27. Hellman J, Tehan MM and Warren HS. Murein lipoprotein, peptidoglycan-associated lipoprotein, and outer membrane protein A are present in purified rough and smooth lipopolysaccharides. J Infect Dis 2003, 188: 286-289.
28. Merien F, Baranton G and Perolat P. Invasion of Vero Cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are Correlated with Virulence. Infect Immun 1997, 65: 729-738.
29. Li LW, Liu YY, Yan J, Mao YF, Luo YH and Li SP. Apoptosis and ultrastruetural lesions in Vero and J774A.1 cells induced by Leptospira interrogans. Zhejiang Da Xue Xue Bao Yi Xue Ban 2005, 34: 4-8.
30. Yan J, Dai BM and Yu ES. Leptospirosis, 3th ed. China: People Health Press, 2006, 310-313.
31. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW and Carroll JD, et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999, 274: 33419-33425.
32. Anders HJ, Banas B and Schlöndorff D. Signaling danger: Toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004, 15: 854-867.
33. Yang CW, Hung CC, Wu MS, Tian YC, Chang CT, Pan MJ and Vandewalle A. Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int 2006, 69: 815-822.
34. Romero JC, Lahera V and Salom MG. Role of the endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol 1992, 2: 1371-1387.
35. Liang M and Knox FG. Production and functional roles of nitric oxide in the proximal tubule. Am J Physiol Regul Integr Comp Physiol 2000, 278: R1117-R1124.
36. Bian K, Ke Y, Kamisaki Y and Murad F. Proteomic modification by nitric oxide. J Pharmacol Sci 2006, 101: 271-279.
37. Guzik TJ, Korbut R and Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J physiol pharmacol 2003, 54: 469-487.
38. Tang WW, Qi M, Warren JS and Van GY. Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 1997, 159: 870-876.
39. Lloyd CM, Dorf ME, Proudfoot A, Salant DJ and Gutierrez-Ramos JC. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukoc Biol 1997, 62: 676-680.
40. Rovin BH, Yoshiumura T and Tan L. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 1992, 148: 2148-2153.
41. Schmouder RL, Strieter RM and Kunkel SL. Interferon-gamma regulation of human renal cortical epithelial cell derived monocyte chemotactio peptide-1. Kidney Int 1993, 44: 43-49.
42. Prodjosudjadi W, Gerritsma JS, Klar-Mohamad N, Gerritsen AF, Bruijn JA, Daha MR and van Es LA. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 1995, 48: 1477-1486.
43. Wada T, Furuichi K, Sakai N, Iwata Y, Kitagawa K, Ishida Y and Kondo T, et al. Gene therapy via blockade of monecyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 2004, 65: 940-948.